Literature DB >> 15955383

Characteristics of basal insulin requirements by age and gender in Type-1 diabetes patients using insulin pump therapy.

Gary Scheiner1, Bret A Boyer.   

Abstract

Establishment of appropriate basal insulin levels is an essential component of intensive insulin therapy. While the existence of a "dawn phenomenon" is widely recognized, the present study sought to establish whether diurnal basal insulin patterns exist in Type-1 diabetes, and whether these patterns vary by age and gender. Participant data was drawn from 322 Type-1 insulin pump users treated at a private diabetes education practice in suburban Philadelphia. All participants completed a battery of fasting tests designed to match basal insulin levels to endogenous glucose production and insulin sensitivity. Analysis of resultant basal patterns revealed significant differences between juvenile (age < or =20) and adult (age >20) basal insulin patterns. The younger group exhibited a more pronounced and sustained night-time peak; the older group exhibiting a briefer and less pronounced early-morning peak. Lower overall basal insulin requirements were found in the youngest (age < or =10) and oldest (age >60) groups. No noteworthy gender differences were found. Results can serve as a guide for clinicians when initiating and fine-tuning patients who utilize basal/bolus insulin therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15955383     DOI: 10.1016/j.diabres.2004.11.005

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  22 in total

1.  Development of a multi-parametric model predictive control algorithm for insulin delivery in type 1 diabetes mellitus using clinical parameters.

Authors:  M W Percival; Y Wang; B Grosman; E Dassau; H Zisser; L Jovanovič; F J Doyle
Journal:  J Process Control       Date:  2011-03-01       Impact factor: 3.666

2.  The use of insulin pumps in youth with type 1 diabetes.

Authors:  David M Maahs; Lauren A Horton; H Peter Chase
Journal:  Diabetes Technol Ther       Date:  2010-06       Impact factor: 6.118

3.  Letter to the editor. A study that glucose control can be achieved in 31 type 1 patients who follow a controlled diet and use an insulin pump that is programmed.

Authors:  John Walsh; Ruth Roberts
Journal:  J Diabetes Sci Technol       Date:  2007-07

Review 4.  Use of technology when assessing adherence to diabetes self-management behaviors.

Authors:  Kimberly A Driscoll; Deborah Young-Hyman
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

5.  Ongoing Debate About Models for Artificial Pancreas Systems and In Silico Studies.

Authors:  Gregory P Forlenza
Journal:  Diabetes Technol Ther       Date:  2018-03       Impact factor: 6.118

6.  Twenty-Four Hour Fasting (Basal Rate) Tests to Achieve Custom-Tailored, Hour-by-Hour Basal Insulin Infusion Rates in Patients With Type 1 Diabetes Using Insulin Pumps (CSII).

Authors:  Michael A Nauck; Anna M Lindmeyer; Chantal Mathieu; Juris J Meier
Journal:  J Diabetes Sci Technol       Date:  2019-10-21

7.  A robust sliding mode controller with internal model for closed-loop artificial pancreas.

Authors:  Amjad Abu-Rmileh; Winston Garcia-Gabin; Darine Zambrano
Journal:  Med Biol Eng Comput       Date:  2010-07-24       Impact factor: 2.602

8.  Insulin doses before and one year after pump start: children have a reversed dawn phenomenon.

Authors:  Tom Nicolajsen; Andreas Samuelsson; Ragnar Hanas
Journal:  J Diabetes Sci Technol       Date:  2012-05-01

9.  Glucose Prediction under Variable-Length Time-Stamped Daily Events: A Seasonal Stochastic Local Modeling Framework.

Authors:  Eslam Montaser; José-Luis Díez; Jorge Bondia
Journal:  Sensors (Basel)       Date:  2021-05-04       Impact factor: 3.576

10.  Changes in Insulin Requirements From the Onset of Continuous Subcutaneous Insulin Infusion (CSII) Until Optimization of Glycemic Control.

Authors:  Ana Chico; Diana Tundidor; Lluis Jordana; Ignasi Saigi; Miguel A Maria; Rosa Corcoy; A de Leiva
Journal:  J Diabetes Sci Technol       Date:  2014-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.